Join our Community and subscribe to our eNewsletters
Sign-up now! or Log in
Home

Learn about Anaplastic

FACT Clinical Trial: Fosbretabulin in Anaplastic Cancer of the Thyroid

This clinical trial is no longer enrolling patients -- Tumor vascular disrupting agent combined with chemotherapy
Cancer specialists now are enrolling candidates for a clinical trial to study the safety and effectiveness of a new treatment for anaplastic thyroid cancer.

Hurthle Cell Thyroid Tumor

Hurthle Cell Thyroid Cancer- Not Quite the Same as Follicular Cancer
Syndicate content